Director/PDMR Shareholding

Origin Enterprises Plc
10 August 2023
 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Christopher Richards

 

Reason for the notification

 

a)

Position/status

Non-Executive Director / PDMR

 

b)

Initial Notification Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Origin Enterprises plc

 

b)

LEI

213800AIB4U7N5BLS350

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument,

type of

instrument

Identification code

Origin Enterprises plc Ordinary Shares of €0.01 each

 

IE00B1WV4493

b)

Nature of the transaction  

Disposal of 4,275 shares held in Christopher Richards' own dealing account and acquisition of 4,275 shares by Christopher Richards via an ISA.

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

€3.24 (disposal)

4,275

€3.247 (acquisition)

4,275

d)

Aggregated information

- Aggregated volume

- Price

 

Price(s)

Aggregated Volume(s)

Aggregated Price (s)

€3.24 (disposal)

4,275

€13,851.00

€3.247 (acquisition)

4,275

€13,880.93

e)

Date of the transaction

9 August 2023

f)

Place of the transaction

London, U.K.

g)

Additional Information

No change in number of shares beneficially held by PDMR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100